Literature DB >> 17235724

Perception of airway obstruction and airway inflammation in asthma: a review.

Elisabetta Rosi1, Loredana Stendardi, Barbara Binazzi, Giorgio Scano.   

Abstract

Dyspnea has a multifactorial nature and the exact mechanism that causes breathlessness in asthma is not fully understood. There is compelling evidence that factors other than merely mechanical ones take part in the pathophysiology of breathlessness. Some recent reports attribute airway inflammation, which may contribute to the unexplained variability in the perception of dyspnea associated with bronchoconstriction. Eosinophil airway inflammation has been proposed as a determinant of breathlessness via mechanisms affecting either the mechanical pathways that control breathlessness or the afferent nerves involved in perception of dyspnea. In this review, data on the interrelation between inflammation and dyspnea sensation and the impact of treatment on dyspnea sensation are discussed. We conclude that regardless of whether mechanical or chemical inflammatory factors are involved, much variability in dyspnea scores remains unexplained.

Entities:  

Mesh:

Year:  2006        PMID: 17235724     DOI: 10.1007/s00408-005-2590-z

Source DB:  PubMed          Journal:  Lung        ISSN: 0341-2040            Impact factor:   2.584


  65 in total

1.  Prostaglandin E2 inhalation increases the sensation of dyspnea during exercise.

Authors:  O Taguchi; Y Kikuchi; W Hida; N Iwase; S Okabe; T Chonan; T Takishima
Journal:  Am Rev Respir Dis       Date:  1992-06

2.  Influence of treatment with beclomethasone, cromoglycate and theophylline on perception of bronchoconstriction in patients with bronchial asthma.

Authors:  C M Higgs; G Laszlo
Journal:  Clin Sci (Lond)       Date:  1996-03       Impact factor: 6.124

Review 3.  Respiratory muscles and dyspnea.

Authors:  K J Killian; N L Jones
Journal:  Clin Chest Med       Date:  1988-06       Impact factor: 2.878

4.  Do inhaled corticosteroids affect perception of dyspnea during bronchoconstriction in asthma?

Authors:  R Ottanelli; E Rosi; I Romagnoli; M Grazzini; L Stendardi; R Duranti; G Scano
Journal:  Chest       Date:  2001-09       Impact factor: 9.410

5.  Distinguishable types of dyspnea in patients with shortness of breath.

Authors:  P M Simon; R M Schwartzstein; J W Weiss; V Fencl; M Teghtsoonian; S E Weinberger
Journal:  Am Rev Respir Dis       Date:  1990-11

Review 6.  Mucosal inflammation in asthma.

Authors:  R Djukanović; W R Roche; J W Wilson; C R Beasley; O P Twentyman; R H Howarth; S T Holgate
Journal:  Am Rev Respir Dis       Date:  1990-08

7.  Sputum in severe exacerbations of asthma: kinetics of inflammatory indices after prednisone treatment.

Authors:  M M Pizzichini; E Pizzichini; L Clelland; A Efthimiadis; J Mahony; J Dolovich; F E Hargreave
Journal:  Am J Respir Crit Care Med       Date:  1997-05       Impact factor: 21.405

8.  Dyspnoea perception during clinical remission of atopic asthma.

Authors:  L M van den Toorn; S E Overbeek; J B Prins; H C Hoogsteden; J C De Jongste
Journal:  Eur Respir J       Date:  2002-06       Impact factor: 16.671

9.  Effects of bronchoconstriction and external resistive loading on the sensation of dyspnea.

Authors:  O Taguchi; Y Kikuchi; W Hida; N Iwase; M Satoh; T Chonan; T Takishima
Journal:  J Appl Physiol (1985)       Date:  1991-12

10.  Relationship among mediators, inflammation, and volume history with antigen versus hyperpnea challenge in guinea pigs.

Authors:  E P Ingenito; J J Godleski; L B Pliss; B M Pichurko; R H Ingram
Journal:  Am Rev Respir Dis       Date:  1992-11
View more
  6 in total

1.  Asthma Control Assessment in Children: Correlation between Asthma Control Test and Peak Expiratory Flow.

Authors:  Eugenia Buzoianu; Mariana Moiceanu; Doina Anca Plesca
Journal:  Maedica (Buchar)       Date:  2014-12

2.  Determining the Best Tool Comparable with Global Initiative for Asthma Criteria for Assessing Pediatric Asthma Control.

Authors:  Ayşegül Akan; Emine Dibek Mısırlıoğlu; Ersoy Civelek; Can Naci Kocabaş
Journal:  Pediatr Allergy Immunol Pulmonol       Date:  2021-08-24       Impact factor: 0.885

3.  A halotyrosine antibody that detects increased protein modifications in asthma patients.

Authors:  Hongjun Jin; Teal S Hallstrand; Don S Daly; Melissa M Matzke; Parameswaran Nair; Diana J Bigelow; Joel G Pounds; Richard C Zangar
Journal:  J Immunol Methods       Date:  2013-12-02       Impact factor: 2.303

4.  Physical deconditioning as a cause of breathlessness among obese adolescents with a diagnosis of asthma.

Authors:  Yun M Shim; Autumn Burnette; Sean Lucas; Richard C Herring; Judith Weltman; James T Patrie; Arthur L Weltman; Thomas A Platts-Mills
Journal:  PLoS One       Date:  2013-04-23       Impact factor: 3.240

5.  Structural brain changes related to disease duration in patients with asthma.

Authors:  Andreas von Leupoldt; Stefanie Brassen; Hans Jörg Baumann; Hans Klose; Christian Büchel
Journal:  PLoS One       Date:  2011-08-19       Impact factor: 3.240

Review 6.  Clinical asthma phenotypes in the real world: opportunities and challenges.

Authors:  Clementine Bostantzoglou; Vicky Delimpoura; Konstantinos Samitas; Eleftherios Zervas; Frank Kanniess; Mina Gaga
Journal:  Breathe (Sheff)       Date:  2015-09
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.